The University of Chicago

Dong Research Group

Welcome to Dong Group!

See more

Research Talks

Check the videos where Professor Dong discusses the research in our group.

See more

Group News

Our JACS Video Byte: Escape from Palladium: Nickel-Catalyzed Catellani Annulation by Jingfeng Huo, Yue Fu, Melody J. Tang, Peng Liu, and Guangbin Dong is now available on ACS YouTube channel!

See more

Research Highlights

Ortho-C–H Methoxylation of Aryl Halides Enabled by a Polarity Reversed N–O Reagent

See More

Research Highlights

Modular synthesis of 1,2-azaborines via ring-opening BN-isostere benzannulation

See More

Research Highlights

Rhodium-Catalyzed Diastereo- and Enantioselective Divergent Annulations between Cyclobutanones and 1,5-Enynes: Repaid Construction of Complex C(sp3)-Rich Scaffolds

See More

Research Highlights

Iridium-Catalyzed Intramolecular β-C–H Alkenylation of Ketones with Alkynes via a Hydride-Transfer Approach

See More

Research Directions

Our research interests is to harness the power of transition-metal catalysts to address the challenges in the arena of chemoselectivity and multi-step synthesis. Our research philosophy is guided by three questions:

1) What would be the most efficient way to introduce functional groups into (small or large) organic molecules?

2) What would be the most efficient method to synthesize various molecular skeletons (bridged or fused rings) with high complexity?

3) What would be the most efficient strategy to access mutiple structurally complicated and biologically important natural products and their analogues in a rapid fashion?

NEWS

Congrats, Rui

Congratulations to Dr. Rui Zhang for defending his Ph.D.! He will move to Cornell University for postdoc research! We wish him all the best in his new page of life!

Our Graduate Student Wins the Prestigious BMS Fellowship!

Zining, the fourth-year graduate student in our group, has been awarded the prestigious BMS fellowship for his achievements in Synthetic Organic Chemistry! Congratulations to him! Each year, Bristol-Myers Squibb, a leading biopharmaceutical company, selects...